Senior insider sale
SVP, General Counsel at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.28M
13.11K shares
What this filing means
LIU JOY plans to sell 13.11K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.28M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001959173-26-003191
Officer· SVP, General Counsel
Since Mar 2021
13.11K
Shares to sell
$6.28M
Approx. market value
1.10K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/24/2025
1.10KTotal acquired1.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2025 | Restricted Stock Vesting Compensation | 1.10K | — |
| Total | 1.10K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
978.00
Market value
$439.3K
4/1/2026
—Completed
Units to sell
892.00
Market value
$442.4K
3/2/2026
—Completed
Units to sell
9.32K
Market value
$4.56M
2/13/2026
—Completed
Units to sell
812.00
Market value
$375.3K
2/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.10K
Market value
$469.2K
5/1/2026
Total
Units
13.11K
Value
$6.28M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 978.00 | $439.3K | — | Completed |
3/2/2026 | 892.00 | $442.4K | — | Completed |
2/13/2026 | 9.32K | $4.56M | — | Completed |
2/12/2026 | 812.00 | $375.3K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 1.10K | $469.2K | NASDAQ | Planned |
| Total | 13.11K | $6.28M | ||